Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Residential crowding and severe respiratory syncytial virus disease among infants and young children: a systematic literature review.

Colosia AD, Masaquel A, Hall CB, Barrett AM, Mahadevia PJ, Yogev R.

BMC Infect Dis. 2012 Apr 20;12:95. doi: 10.1186/1471-2334-12-95. Review.

2.

Systematic literature review assessing tobacco smoke exposure as a risk factor for serious respiratory syncytial virus disease among infants and young children.

DiFranza JR, Masaquel A, Barrett AM, Colosia AD, Mahadevia PJ.

BMC Pediatr. 2012 Jun 21;12:81. doi: 10.1186/1471-2431-12-81. Review.

3.

Comparison of risk factors for human metapneumovirus and respiratory syncytial virus disease severity in young children.

Papenburg J, Hamelin MÈ, Ouhoummane N, Carbonneau J, Ouakki M, Raymond F, Robitaille L, Corbeil J, Caouette G, Frenette L, De Serres G, Boivin G.

J Infect Dis. 2012 Jul 15;206(2):178-89. doi: 10.1093/infdis/jis333.

4.

Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group.

Rodriguez WJ, Gruber WC, Welliver RC, Groothuis JR, Simoes EA, Meissner HC, Hemming VG, Hall CB, Lepow ML, Rosas AJ, Robertsen C, Kramer AA.

Pediatrics. 1997 Mar;99(3):454-61.

PMID:
9041304
5.

Risk factors for severe respiratory syncytial virus infection among Alaska native children.

Bulkow LR, Singleton RJ, Karron RA, Harrison LH; Alaska RSV Study Group..

Pediatrics. 2002 Feb;109(2):210-6.

PMID:
11826197
6.

Risk factors for respiratory syncytial virus associated with acute lower respiratory infection in children under five years: Systematic review and meta-analysis.

Shi T, Balsells E, Wastnedge E, Singleton R, Rasmussen ZA, Zar HJ, Rath BA, Madhi SA, Campbell S, Vaccari LC, Bulkow LR, Thomas ED, Barnett W, Hoppe C, Campbell H, Nair H.

J Glob Health. 2015 Dec;5(2):020416. doi: 10.7189/jogh.05.020416. Review.

7.

Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.

Simoes EA, Carbonell-Estrany X.

Pediatr Infect Dis J. 2003 Feb;22(2 Suppl):S13-8; discussion S18-20.

PMID:
12671448
8.

Risk factors for severe respiratory syncytial virus infection leading to hospital admission in children in the Western Region of The Gambia.

Weber MW, Milligan P, Hilton S, Lahai G, Whittle H, Mulholland EK, Greenwood BM.

Int J Epidemiol. 1999 Feb;28(1):157-62.

9.

Outpatient RSV lower respiratory infections among high-risk infants and other pediatric populations.

Paramore LC, Mahadevia PJ, Piedra PA.

Pediatr Pulmonol. 2010 Jun;45(6):578-84. doi: 10.1002/ppul.21224.

PMID:
20503283
11.

Respiratory syncytial virus infection in Navajo and White Mountain Apache children.

Bockova J, O'Brien KL, Oski J, Croll J, Reid R, Weatherholtz RC, Santosham M, Karron RA.

Pediatrics. 2002 Aug;110(2 Pt 1):e20.

PMID:
12165619
12.

Sequelae of severe respiratory syncytial virus infection in infancy and early childhood among Alaska Native children.

Singleton RJ, Redding GJ, Lewis TC, Martinez P, Bulkow L, Morray B, Peters H, Gove J, Jones C, Stamey D, Talkington DF, DeMain J, Bernert JT, Butler JC.

Pediatrics. 2003 Aug;112(2):285-90.

PMID:
12897275
13.
14.

The association between respiratory syncytial virus infection and the development of childhood asthma: a systematic review of the literature.

Pérez-Yarza EG, Moreno A, Lázaro P, Mejías A, Ramilo O.

Pediatr Infect Dis J. 2007 Aug;26(8):733-9.

PMID:
17848887
15.

Severe respiratory syncytial virus disease in Alaska native children. RSV Alaska Study Group.

Karron RA, Singleton RJ, Bulkow L, Parkinson A, Kruse D, DeSmet I, Indorf C, Petersen KM, Leombruno D, Hurlburt D, Santosham M, Harrison LH.

J Infect Dis. 1999 Jul;180(1):41-9.

16.
17.

Respiratory syncytial virus morbidity, premorbid factors, seasonality, and implications for prophylaxis.

Hon KL, Leung TF, Cheng WY, Ko NM, Tang WK, Wong WW, Yeung WH, Chan PK.

J Crit Care. 2012 Oct;27(5):464-8. doi: 10.1016/j.jcrc.2011.12.001.

PMID:
22227087
18.

Impact of palivizumab prophylaxis on respiratory syncytial virus hospitalizations in high risk Alaska Native infants.

Singleton R, Dooley L, Bruden D, Raelson S, Butler JC.

Pediatr Infect Dis J. 2003 Jun;22(6):540-5.

PMID:
12799511
19.

Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children.

Iwane MK, Edwards KM, Szilagyi PG, Walker FJ, Griffin MR, Weinberg GA, Coulen C, Poehling KA, Shone LP, Balter S, Hall CB, Erdman DD, Wooten K, Schwartz B; New Vaccine Surveillance Network..

Pediatrics. 2004 Jun;113(6):1758-64.

PMID:
15173503
20.

Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections.

American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn..

Pediatrics. 2003 Dec;112(6 Pt 1):1442-6.

PMID:
14654627
Items per page

Supplemental Content

Support Center